Germany-based biotechnology company Sphingotec has introduced a simple blood test to quantify individual risk of developing breast cancer in women. The test, sphingotest pro-NT, enables gynecologists, family doctors and clinical ...
Tags: Germany, Sphingotec, blood test, individual risk, breast cancer
Medical researchers at the University of Melbourne have made a discovery that could lead to a simple blood test for Creutzfeldt-Jakob Disease (CJD) and Mad Cow disease. Using genetic sequencing, the scientists found that cells infected ...
Atherotech Diagnostics Lab, a CLIA-certified clinical reference laboratory, has entered into an agreement to offer BG Medicine's galectin-3 testing services to laboratory customers and physicians. To offer the services, Atherotech is ...
BG Medicine's CardioSCORE test has received CE Mark, which enables the commercial sale of it in the EU and other countries that recognize the CE Mark. The CardioSCORE test is a patented diagnostic blood test designed to improve risk ...
Tags: BG Medicine, Cardioscore Test, blood test, Medicine
BG Medicine has obtained CE mark approval for its diagnostic blood assay, CardioSCORE, designed for identifying individuals who are at high risk for near-term major cardiovascular events including heart attack and stroke. The multivariate ...
MicroPhage has gained an additional FDA 510 clearance for its KeyPath MRSA/MSSA Blood Culture Test-BT. Blood test was initially cleared to diagnose and distinguish methicillin resistant and methicillin sensitive Staphylococcus aureus ...
Tags: MicroPhage, KeyPath platform, MRSA/MSSA Blood Culture Test-BT
Sequenom's European licensing partner LifeCodexx has launched its Praena test service in more than 70 prenatal clinics and hospitals in Germany, Austria, Liechtenstein and Switzerland following the CE mark approval. LifeCodexx CEO Michael ...
Tags: Praena test, LifeCodexx, Sequenom
BG Medicine has filed 510(k) premarket notification for regulatory clearance of an expanded indication for its BGM Galectin-3 test with the FDA. The blood test is at present indicated for use in patients with chronic heart failure who are ...
Tags: BG Medicine, blood test, heart failure
DiaGenic has teamed up with GE Healthcare to develop a blood-based test using DiaGenic's peripheral gene expression profiling in patients with mild cognitive impairment, a disorder associated with risk for Alzheimer's Disease. The ...
Tags: DiaGenic, GE Healthcare, Alzheimer's Disease
Verinata Health has introduced a non-invasive prenatal test to detect autosomal and fetal sex chromosome aneuploidies for high-risk pregnancies. The expanded indication of verifi prenatal blood test detects Turner syndrome(Monosomy ...
Tags: Verinata Health, non-invasive prenatal test, high-risk pregnancies
Ortho Clinical Diagnostics' Vitros Immunodiagnostic Product 25-OH Vitamin D Total assay has received CE mark approval. The Vitros 25-OH Vitamin D Total assay is a new diagnostic blood test designed to measure levels of vitamin D2 and ...
CML HealthCare, a provider of medical diagnostic services, has introduced a new blood-based diagnostic test for colorectal cancer. The new COLOGIC test is designed for screening patients who are at high risk for colorectal cancer and ...
Tags: medical diagnostic services, blood-based diagnostic test, COLOGIC test
Alere has presented positive results from PELICAN clinical trial,designed to assess the safety and efficacy of Triage placental growth factor (PlGF) blood test in diagnosing pre-eclampsia in women with suspected pre-eclampsia before 35 ...
Tags: PlGF Blood Test, placental growth factor blood test, PlGF testing
The US Food and Drug Administration (FDA) has granted premarket approval (PMA) to Beckman Coulter's simple, non-invasive Prostate Health Index (phi) blood test. The phi test, indicated for use in men with a prostate-specific antigen (PSA) ...
Tags: phi blood test, Prostate Health Index Test, immunoassay systems
Corgenix, a subsidiary of Corgenix Medical, has signed a five-year contract manufacturing and supply agreement with diaDexus. As per the agreement, Corgenix will manufacture and supply the PLAC blood test ELISA product for diaDexus. The ...